Cancer stem cells and chemoresistance: The smartest survives the raid - Wikidata - wikimedia - TriplyDB

Cancer stem cells and chemoresistance: The smartest survives the raid

Cancer stem cells and chemoresistance: The smartest survives the raid

http://www.wikidata.org/entity/Q36730432

about

Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer Chemoresistance and targeted therapies in ovarian and endometrial cancers Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas.Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culture.Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.Repurposing itraconazole as an anticancer agent.Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling Antiproliferative activity of 8-methoxypsoralen on DU145 prostate cancer cells under UVA and blue light.Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells.Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes.Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden.Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1.Targeting deubiquitinating enzymes in cancer stem cells.Cancer Cell Plasticity: Rapid Reversal of Chemosensitivity and Expression of Stemness Markers in Lung and Breast Cancer Tumorspheres.Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery.Two novel diterpenoid heterodimers, Bisebracteolasins A and B, from Euphorbia ebracteolata Hayata, and the cancer chemotherapeutic potential of Bisebracteolasin A.A novel polyamine blockade therapy activates an anti-tumor immune response.Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells.Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway.Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.NEAT1 acts as an inducer of cancer stem cell-like phenotypes in NSCLC by inhibiting EGCG-upregulated CTR1.Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.Targeting Stemness: Implications for Precision Medicine in Breast Cancer.Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation.On-slide detection of enzymatic activities in selected single cells.Glioma-Associated Oncogene Homolog Inhibitors Have the Potential of Suppressing Cancer Stem Cells of Breast Cancer.Extremely Low-Frequency Magnetic Fields and Redox-Responsive Pathways Linked to Cancer Drug Resistance: Insights from Co-Exposure-Based In Vitro Studies.Cancer stem cells as key drivers of tumour progression.More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis.Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor

P2860

Q26741846-A539E741-70BB-43E2-AD78-E81C886CA5DE Q28073246-57DFD160-77DA-4829-8E24-B3C5F61EF682 Q28552301-7734397F-3694-45A3-AAE9-1201D4738A0E Q28831422-2A00F792-DD71-4251-B7EA-B1B647BC03BD Q33596189-28A464DF-F75C-48BA-B35A-5DEEB3890616 Q38369383-1353A68A-9331-4406-89E2-51242666BE63 Q38603815-A8A67381-68D8-4090-8ED0-AEEF40363E30 Q38633691-AB1B4FEA-6694-4923-817B-75AF7B363228 Q38724559-5554BD96-AF92-4A7B-A26D-33F37C478A60 Q38730270-9702F18A-AF7D-46D3-ADA2-DF0F1D87C284 Q38784131-03EE6B8A-8F52-4EF7-88FB-43EB4B4AC4DB Q38902610-D07238C4-758F-407C-9F2A-94515B1E9501 Q40608521-6094C385-9AD3-456F-8184-1F1B99B87544 Q41469992-F129163D-AC76-450F-A368-7AB260C5D492 Q41837007-5A643790-20D7-4345-9C68-E33289447821 Q44948244-10978763-8761-476F-9808-444E578D2A39 Q45048442-0183450C-72AC-4A59-9982-28BC3A879B31 Q47108689-6E5C9FDE-4ECC-43D6-9086-357BC5676712 Q47118244-4A393A3E-B056-410B-96D9-380CCBB800F4 Q47138729-CA3731E5-CA21-4ACA-A766-7BCA0FE734FA Q47726651-20726882-576A-471A-93A5-8FFE0E2CD266 Q48121718-2D2E4DE3-6DED-4A3C-9314-BE55275B27C8 Q48267099-DF021E72-68B5-4894-9592-678378A580AF Q48274541-F9C21874-0995-4AE1-8506-C7FD8608304E Q49237718-3398489F-B28A-493F-9F72-A62534B837F4 Q49387560-5D69E2BC-9828-4FF7-BEF9-904D733A432C Q49544368-72CBFC39-77E5-4487-B200-CCE7A5D7DEFB Q50147073-CC7E3CA7-0D82-4DDF-8D36-EA348D5DC355 Q52522309-D90C7B79-C9D4-4052-8604-17EDEA3DD14D Q53769826-FFA33B29-4B39-4D41-8583-CDC94EC7B25A Q55107351-D1948A56-289E-4808-9A81-A37D16EF4FEC Q55122201-E834DF1C-8D39-4FA1-997D-A18EF6CA0D5F Q55281738-DAB868A2-2D8F-4555-BFCD-859F7B3DBD09 Q57024281-4CBC22A5-52F4-4017-AC05-2AA9F7C64ACA Q58609015-544F793B-E497-421D-A47E-807A9677DC7E Q58790039-3A8AC7A4-DEBD-4CE1-A2E0-7EE02A300F16 Q58793639-A167FE3D-20D6-4811-8D3A-44A143EA013A

P2860

Cancer stem cells and chemoresistance: The smartest survives the raid

http://www.wikidata.org/entity/Q36730432

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cancer stem cells and chemoresistance: The smartest survives the raid

@ast

Cancer stem cells and chemoresistance: The smartest survives the raid

@en

type

label

Cancer stem cells and chemoresistance: The smartest survives the raid

@ast

Cancer stem cells and chemoresistance: The smartest survives the raid

@en

prefLabel

Cancer stem cells and chemoresistance: The smartest survives the raid

@ast

Cancer stem cells and chemoresistance: The smartest survives the raid

@en

P1433

Q36730432-B4A6E683-D879-47B8-88B7-1570D3B8AD07

P1476

Q36730432-F290F4EB-3407-4890-9618-FACF23D7416E

P2093

Q36730432-0DF430ED-52CF-401A-89E7-46EB5F6EF82A

P2860

Q36730432-0134C729-1B16-4872-A731-7FD27B9AFE79

Q36730432-013A1E07-A2F5-4207-8CEC-549241481E0B

Q36730432-02782271-3166-449D-AAF5-17D1D806CBBE

Q36730432-02DE25DD-1F1E-417C-8708-A9D762F2217A

Q36730432-0340D472-AA1B-42B7-828C-508152789515

Q36730432-0462249A-8249-4E98-A6A8-58AE991D8FFD

Q36730432-04D6AA6A-4A60-4CEF-95FB-BA805D804B0E

Q36730432-04D9CBA6-2A6F-42EA-9062-826B569B8CDE

Q36730432-05AAB414-EEB1-454E-8C2F-AD8013A7EE02

Q36730432-05B34745-0B1A-49CE-A92C-DAAF19F07437

P304

Q36730432-3AF536F0-7013-4CF2-8D57-193816EDC930

P31

Q36730432-DEFB2E43-5525-48F8-A589-A84161D8598D

P356

Q36730432-EC7BB151-DC97-4458-8B63-C354B1120587

P478

Q36730432-FC2D7A7D-3EAB-4BD3-8732-93CD095F2177

P577

Q36730432-85964E8A-7DFA-4C3D-9DCD-1A948C2B4684

P698

Q36730432-F0CC1349-30FA-442A-B54C-C42CBAA7B82C

P932

Q36730432-D3018828-E5AC-44F1-8421-24DAEB84A5DC

P356

J.PHARMTHERA.2016.02.008

P1433

Pharmacology & Therapeutics

P1476

Cancer stem cells and chemoresistance: The smartest survives the raid

@en

P2093

Jihe Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.

ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal

A multidrug resistance transporter from human MCF-7 breast cancer cells

Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

DNA damage-mediated induction of a chemoresistant niche

ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression

The epithelial-mesenchymal transition generates cells with properties of stem cells

P304

145-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PHARMTHERA.2016.02.008

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26899500

http://www.w3.org/2001/XMLSchema#string

P932

4808328

http://www.w3.org/2001/XMLSchema#string